Pulmonary-Specific Intermountain Risk Score Predicts All-Cause Mortality via Spirometry, the Red Cell Distribution Width, and Other Laboratory Parameters

References

1. 1.↵
   1. Vestbo J,
   2. Hurd SS,
   3. Agustí AG,
   4. Jones PW,
   5. Vogelmeier C,
   6. Anzueto A,
   7. et al

   . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187(4):347–365.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Lee HM,
   2. Le H,
   3. Lee BT,
   4. Lopez VA,
   5. Wong ND

   . Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality. Eur Respir J 2010;36(5):1002–1006.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Sin DD,
   2. Wu L,
   3. Man SF

   . The relationship between reduced lung function and cardiovascular mortality. Chest 2005;127(6):1952–1959.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Horne BD,
   2. May HT,
   3. Muhlestein JB,
   4. Ronnow BS,
   5. Lappé DL,
   6. Renlund DG,
   7. et al

   . Exceptional mortality prediction by risk scores from common laboratory tests. Am J Med 2009;122(6):550–558.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.
   1. Horne BD,
   2. May HT,
   3. Kfoury AG,
   4. Renlund DG,
   5. Muhlestein JB,
   6. Lappé DL,
   7. et al

   . The Intermountain Risk Score (including the red cell distribution width) predicts heart failure and other morbidity endpoints. Eur J Heart Fail 2010;12(11):1203–1213.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Anderson JL,
   2. Ronnow BS,
   3. Horne BD,
   4. Carlquist JF,
   5. May HT,
   6. Bair TL,
   7. et al

   . Usefulness of a complete blood count-derived risk score to predict incident mortality in patients with suspected cardiovascular disease. Am J Cardiol 2007;99(2):169–174.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Miller MR,
   2. Hankinson J,
   3. Brusasco V,
   4. Burgos F,
   5. Casaburi R,
   6. Coates A,
   7. et al

   . Standardisation of spirometry. Eur Respir J 2005;26(2):319–338.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Hankinson JL,
   2. Odencrantz JR,
   3. Fedan KB

   . Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999;159(1):179–187.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Hayes SN,
   2. Redberg RF

   . Dispelling the myths: calling for sex-specific reporting of trial results. Mayo Clin Proc 2008;83(5):523–525.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Cooper A,
    2. O'Flynn N

    , Guideline Development Group. Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance. BMJ 2008;336(7655):1246–1248.

    OpenUrlFREE Full Text
11. 11.↵
    British Cardiac Society, British Hypertension Society, Diabetes UK, HEART UK, Primary Care Cardiovascular Society, Stroke Association. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005;91(suppl 5):v1–v52.

    OpenUrlFREE Full Text
12. 12.↵
    1. Zimmerman JE,
    2. Kramer AA,
    3. McNair DS,
    4. Malila FM

    . Acute physiology and chronic health evaluation (APACHE) IV: hospital mortality assessment for today's critically ill patients. Crit Care Med 2006;34(5):1297–1310.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Celli BR,
    2. Cote CG,
    3. Marin JM,
    4. Casanova C,
    5. Montes de Oca M,
    6. Mendez RA,
    7. et al

    . The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350(10):1005–1012.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Puhan MA,
    2. Garcia-Aymerich J,
    3. Frey M,
    4. ter Riet G,
    5. Antó JM,
    6. Agustí AG,
    7. et al

    . Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 2009;374(9691):704–711.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Roche N,
    2. Rabbat A,
    3. Zureik M,
    4. Huchon G

    . Chronic obstructive pulmonary disease exacerbations in emergency departments: predictors of outcome. Curr Opin Pulm Med 2010;16(2):112–117.

    OpenUrlPubMed
16. 16.↵
    1. Eisner MD,
    2. Omachi TA,
    3. Katz PP,
    4. Yelin EH,
    5. Iribarren C,
    6. Blanc PD

    . Measurement of COPD severity using a survey-based score. Chest 2010;137(4):846–851.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Horne BD,
    2. Lappé DL,
    3. Muhlestein JB,
    4. May HT,
    5. Ronnow BS,
    6. Brunisholz KD,
    7. et al

    . Repeated measurement of the Intermountain Risk Score enhances prognostication for mortality. PLoS One 2013;8(7):e69160.

    OpenUrlPubMed
18. 18.↵
    1. Horne BD,
    2. Anderson JL,
    3. Muhlestein JB,
    4. Ridker PM,
    5. Paynter NP

    . The complete blood count risk score and its components, including RDW, are associated with mortality in the JUPITER Trial. Eur J Prev Cardiol 2015;22(4):519–526

    OpenUrlAbstract/FREE Full Text